Literature DB >> 11046225

Clinical uses of alpha2 -adrenergic agonists.

T Kamibayashi1, M Maze.   

Abstract

Mesh：

Substances：

Year:  2000        PMID： 11046225     DOI： 10.1097/00000542-200011000-00030

Source DB:  PubMed          Journal:  Anesthesiology        ISSN： 0003-3022            Impact factor:   7.892


× No keyword cloud information.
  198 in total

1.  Discontinuation of prolonged infusions of dexmedetomidine in critically ill children with heart disease.

Authors:  Nelson H Burbano; Andrea V Otero; Donald E Berry; Richard A Orr; Ricardo A Munoz
Journal:  Intensive Care Med       Date:  2011-12-13       Impact factor: 17.440

2.  A randomized controlled trial of the effect of preoperative dexmedetomidine on the half maximal effective concentration of propofol for successful i-gel insertion without muscle relaxants.

Authors:  Young-Eun Jang; Yong-Chul Kim; Hyun-Kyu Yoon; Young-Tae Jeon; Jung-Won Hwang; Eugene Kim; Hee-Pyoung Park
Journal:  J Anesth       Date:  2014-11-14       Impact factor: 2.078

3.  High concentrations of dexmedetomidine inhibit compound action potentials in frog sciatic nerves without alpha(2) adrenoceptor activation.

Authors:  Toshifumi Kosugi; Kotaro Mizuta; Tsugumi Fujita; Mikio Nakashima; Eiichi Kumamoto
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

4.  The potential of metabolomic analysis techniques for the characterisation of α1-adrenergic receptors in cultured N1E-115 mouse neuroblastoma cells.

Authors:  Maria I Wenner; Garth L Maker; Linda F Dawson; Peter D Drummond; Ian Mullaney
Journal:  Cytotechnology       Date:  2015-09-25       Impact factor: 2.058

5.  Neuron specific alpha-adrenergic receptor expression in human cerebellum: implications for emerging cerebellar roles in neurologic disease.

Authors:  U B Schambra; G B Mackensen; M Stafford-Smith; D E Haines; D A Schwinn
Journal:  Neuroscience       Date:  2005       Impact factor: 3.590

6.  Dexmedetomidine ameliorates nocifensive behavior in humanized sickle cell mice.

Authors:  Gabriela Calhoun; Li Wang; Luis E F Almeida; Nicholas Kenyon; Nina Afsar; Mehdi Nouraie; Julia C Finkel; Zenaide M N Quezado
Journal:  Eur J Pharmacol       Date:  2015-02-25       Impact factor: 4.432

Review 7.  Pharmacological and nonpharmacological management of delirium in critically ill patients.

Authors:  Dustin M Hipp; E Wesley Ely
Journal:  Neurotherapeutics       Date:  2012-01       Impact factor: 7.620

Review 8.  Intestinal motility disturbances in intensive care patients pathogenesis and clinical impact.

Authors:  Sonja Fruhwald; Peter Holzer; Helfried Metzler
Journal:  Intensive Care Med       Date:  2006-11-18       Impact factor: 17.440

9.  The impact of perioperative dexmedetomidine infusion on postoperative narcotic use and duration of stay after laparoscopic bariatric surgery.

Authors:  Chirag Dholakia; Gretchen Beverstein; Michael Garren; Christopher Nemergut; John Boncyk; Jon C Gould
Journal:  J Gastrointest Surg       Date:  2007-08-21       Impact factor: 3.452

10.  Efficacy and pharmacokinetics of bupivacaine with epinephrine or dexmedetomidine after intraperitoneal administration in cats undergoing ovariohysterectomy.

Authors:  Javier Benito; Beatriz Monteiro; Francis Beaudry; Paulo Steagall
Journal:  Can J Vet Res       Date:  2018-04       Impact factor: 1.310
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.